{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:57:10Z","timestamp":1766120230424,"version":"3.48.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"DOI":"10.7759\/cureus.99579","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:18:27Z","timestamp":1766117907000},"source":"Crossref","is-referenced-by-count":0,"title":["Cefiderocol Elimination During Peritoneal Dialysis: A Short Report"],"prefix":"10.7759","author":[{"given":"Julian","family":"M\u00fcller-K\u00fchnle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Rittershofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Schanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Allg\u00e4uer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Muerdter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severin","family":"Schricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2476","article-title":"Cefiderocol: a novel siderophore cephalosporin against multidrug-resistant Gram-negative pathogens","volume":"40","author":"Abdul-Mutakabbir JC","year":"2020","unstructured":"Abdul-Mutakabbir JC, Alosaimy S, Morrisette T, Kebriaei R, Rybak MJ. Cefiderocol: a novel siderophore cephalosporin against multidrug-resistant Gram-negative pathogens. Pharmacotherapy. 2020, 40:1228-47. 10.1002\/phar.2476","journal-title":"Pharmacotherapy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01063-5","article-title":"Clinical pharmacokinetics and pharmacodynamics of cefiderocol","volume":"60","author":"Bilal M","year":"2021","unstructured":"Bilal M, El Tabei L, B\u00fcsker S, Krauss C, Fuhr U, Taubert M. Clinical pharmacokinetics and pharmacodynamics of cefiderocol. Clin Pharmacokinet. 2021, 60:1495-508. 10.1007\/s40262-021-01063-5","journal-title":"Clin Pharmacokinet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz828","article-title":"Pharmacokinetic and pharmacodynamic profiles of cefiderocol, a novel siderophore cephalosporin","volume":"69","author":"Katsube T","year":"2019","unstructured":"Katsube T, Echols R, Wajima T. Pharmacokinetic and pharmacodynamic profiles of cefiderocol, a novel siderophore cephalosporin. Clin Infect Dis. 2019, 69:S552-8. 10.1093\/cid\/ciz828","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.841","article-title":"Cefiderocol, a siderophore cephalosporin for Gram-negative bacterial infections: pharmacokinetics and safety in subjects with renal impairment","volume":"57","author":"Katsube T","year":"2017","unstructured":"Katsube T, Echols R, Arjona Ferreira JC, Krenz HK, Berg JK, Galloway C. Cefiderocol, a siderophore cephalosporin for Gram-negative bacterial infections: pharmacokinetics and safety in subjects with renal impairment. J Clin Pharmacol. 2017, 57:584-91. 10.1002\/jcph.841","journal-title":"J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx009","article-title":"Optimization of anti-infective dosing regimens during online haemodiafiltration","volume":"10","author":"Jager NG","year":"2017","unstructured":"Jager NG, Zandvliet AS, Touw DJ, Penne EL. Optimization of anti-infective dosing regimens during online haemodiafiltration. Clin Kidney J. 2017, 10:282-90. 10.1093\/ckj\/sfx009","journal-title":"Clin Kidney J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.7.1424","article-title":"Removal of vancomycin by high-flux hemodialysis membranes","volume":"36","author":"Quale JM","year":"1992","unstructured":"Quale JM, O'Halloran JJ, DeVincenzo N, Barth RH. Removal of vancomycin by high-flux hemodialysis membranes. Antimicrob Agents Chemother. 1992, 36:1424-6. 10.1128\/AAC.36.7.1424","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1021\/pr0702969","article-title":"Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes","volume":"6","author":"Sritippayawan S","year":"2007","unstructured":"Sritippayawan S, Chiangjong W, Semangoen T, et al.. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes. J Proteome Res. 2007, 6:4356-62. 10.1021\/pr0702969","journal-title":"J Proteome Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12701\/jyms.2023.00864","article-title":"Cephalosporin-induced encephalopathy in patients with hematologic malignancies: a significant concern","volume":"40","author":"Park YS","year":"2023","unstructured":"Park YS, Kim MK, Lee KH, Koh SA, Jung JY, Jang BI, Lee SJ. Cephalosporin-induced encephalopathy in patients with hematologic malignancies: a significant concern. J Yeungnam Med Sci. 2023, 40:S137-41. 10.12701\/jyms.2023.00864","journal-title":"J Yeungnam Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/08971900251326735","article-title":"Seizures associated with high-dose cefazolin in a patient with renal dysfunction: a case report","volume":"38","author":"Kingra K","year":"2025","unstructured":"Kingra K, Ariano RE, Sharma A. Seizures associated with high-dose cefazolin in a patient with renal dysfunction: a case report. J Pharm Pract. 2025, 38:529-33. 10.1177\/08971900251326735","journal-title":"J Pharm Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443415-cefiderocol-elimination-during-peritoneal-dialysis-a-short-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:18:30Z","timestamp":1766117910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443415-cefiderocol-elimination-during-peritoneal-dialysis-a-short-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.99579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}